tirzepatide uk approval first country in Europe to reimburse Mounjaro approved for use in

When properly made, both deliver the same 15% to 22% body weight loss over 6 to 12 months

Both are peptides that activate the same two receptors

The only hard rule is the 72-hour minimum on the short side

Choosing a medication should always start with a real conversation with your doctor

In head-to-head trials, tirzepatide users achieved average weight losses of 20.9% over 72 weeks, compared to 16.4% for GLP-1-only medications over similar timeframes

address Unlimited provider messaging access Initial medical consultation and prescription The inclusion of injection supplies is convenient, especially for new users who might not know exactly which syringes to purchase separately